|
|
|
|
Vol. 63, Issue 3, 706-713, March 2003
Microchemical Core Facility, Department of Biology (L.T.W.) and
Department of Chemistry (A.F.K.), San Diego State University, San
Diego, California; and Laboratory of Immunology, National Institute of
Allergy and Infectious Diseases, National Institutes of Health,
Bethesda, Maryland (C.C.C.)
Extracellular ATP is a potent signaling factor that modulates a variety
of cellular functions through the activation of P2 purinergic
receptors. Extracellular ATP at higher concentrations exerts cytostatic
as well as cytotoxic effects in a variety of cell systems, the
mechanism of which is not fully understood. In this study, we used
cultured human embryonic kidney (HEK) cells stably transfected with
human P2X7 receptors (HEK-P2X7) to investigate the mechanism of ATP-induced cell death. The cytotoxic effects of ATP
in HEK-P2X7 cells were dose- and time-dependent, whereas ADP, AMP, and UTP had no effect. ATP treatment induced a significant increase in apoptotic HEK-P2X7 cells as ascertained by the
terminal deoxynucleotidyl transferase dUTP nick-end labeling technique and flow cytometry. An ATP-induced decrease in the pro-apoptotic bax gene expression was detected by
apoptosis-related cDNA microarray analysis, which correlated with a
decrease of Bax protein expression. Western blot analysis revealed that
ATP treatment resulted in the processing of pro-caspase 3 to its active
form and cleavage of the nuclear enzyme, poly(ADP-ribose) polymerase
(PARP). Both ATP-induced molecular alterations in HEK-P2X7
cells (i.e., decrease of Bax expression and increase of PARP cleavage)
were blocked by the purinergic P2X7 receptor antagonist
oxidized ATP. In conclusion, we demonstrated the importance of the
P2X7 receptor in ATP induced cell death of
HEK-P2X7 cells, which seems to be independent of bax expression; however, the activation of caspases is required.
This article has been cited by other articles:
![]() |
A. B. Mackenzie, M. T. Young, E. Adinolfi, and A. Surprenant Pseudoapoptosis Induced by Brief Activation of ATP-gated P2X7 Receptors J. Biol. Chem., October 7, 2005; 280(40): 33968 - 33976. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Gu, R. Sluyter, K. K. Skarratt, A. N. Shemon, L.-P. Dao-Ung, S. J. Fuller, J. A. Barden, A. L. Clarke, S. Petrou, and J. S. Wiley An Arg307 to Gln Polymorphism within the ATP-binding Site Causes Loss of Function of the Human P2X7 Receptor J. Biol. Chem., July 23, 2004; 279(30): 31287 - 31295. [Abstract] [Full Text] [PDF] |
||||